nonmetastatic crpc: mfs and ar-targeted agents
Published 6 years ago • 32 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
3:44
nonmetastatic crpc: initial diagnostic workup
-
4:25
current and future therapies for nonmetastatic crpc
-
4:18
nonmetastatic crpc: other therapies and coordinating care
-
8:30
ar-targeted therapies in crpc
-
4:11
nonmetastatic crpc: other therapies and multimodality approach
-
4:36
nonmetastatic crpc: initial therapeutic approach
-
2:22
understanding nonmetastatic crpc
-
6:18
how to beat castration-resistant prostate cancer today
-
7:46
treating non-metastatic castrate resistant prostate cancer | ask a prostate expert, mark scholz, md
-
3:51
metastatic hormone-sensitive prostate cancer (mhspc)
-
3:21
the rationale for arn-509 in nonmetastatic crpc
-
8:53
utilizing ar-targeted therapies in crpc
-
2:46
clinical data for nonmetastatic crpc
-
3:08
when to treat nonmetastatic crpc
-
0:57
dr. dorff on choosing between therapies in nonmetastatic crpc
-
32:22
emerging treatment options for non - metastatic crpc sept 2018
-
5:50
mfs: a new endpoint for nonmetastatic crpc
-
9:00
differences between ar-targeted therapy in prostate cancer
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
3:06
how ar therapy has changed the nmcrpc treatment landscape
-
1:41
dr. antonarakis on ar-v7 and resistance to ar-targeting agents in mcrpc